Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice

We previously demonstrated that the combination of synthetic small-molecule Toll-like receptor 4 (TLR4) and TLR7 ligands is a potent adjuvant for recombinant influenza virus hemagglutinin, inducing rapid and sustained immunity that is protective against influenza viruses in homologous, heterologous,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Virol
Glavni autori: Goff, Peter H., Hayashi, Tomoko, He, Wenqian, Yao, Shiyin, Cottam, Howard B., Tan, Gene S., Crain, Brian, Krammer, Florian, Messer, Karen, Pu, Minya, Carson, Dennis A., Palese, Peter, Corr, Maripat
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2017
Teme:
Vaccines and Antiviral Agents
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599744/
https://ncbi.nlm.nih.gov/pubmed/28724768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01050-17
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items